KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Other Non-Current Liabilities (2016 - 2025)

Astrana Health (ASTH) has disclosed Other Non-Current Liabilities for 12 consecutive years, with $17.1 million as the latest value for Q4 2025.

  • Quarterly Other Non-Current Liabilities rose 17.09% to $17.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $17.1 million through Dec 2025, up 17.09% year-over-year, with the annual reading at $17.1 million for FY2025, 17.09% up from the prior year.
  • Other Non-Current Liabilities hit $17.1 million in Q4 2025 for Astrana Health, up from $15.9 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $21.8 million in Q1 2023 to a low of $1.2 million in Q2 2021.
  • Historically, Other Non-Current Liabilities has averaged $12.7 million across 5 years, with a median of $13.7 million in 2022.
  • Biggest five-year swings in Other Non-Current Liabilities: soared 1046.95% in 2022 and later plummeted 82.3% in 2023.
  • Year by year, Other Non-Current Liabilities stood at $14.8 million in 2021, then surged by 37.1% to $20.3 million in 2022, then tumbled by 82.3% to $3.6 million in 2023, then skyrocketed by 307.42% to $14.6 million in 2024, then increased by 17.09% to $17.1 million in 2025.
  • Business Quant data shows Other Non-Current Liabilities for ASTH at $17.1 million in Q4 2025, $15.9 million in Q3 2025, and $12.3 million in Q2 2025.